title: Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
authors.forename: Antonella
authors.initials: A
authors.lastname: Meloni
authors.forename: Brunella
authors.initials: B
authors.lastname: Favilli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Positano
authors.forename: Paolo
authors.initials: P
authors.lastname: Cianciulli
authors.forename: Aldo
authors.initials: A
authors.lastname: Filosa
authors.forename: Antonella
authors.initials: A
authors.lastname: Quarta
authors.forename: Domenico
authors.initials: D
authors.lastname: D'Ascola
authors.forename: Gennaro
authors.initials: G
authors.lastname: Restaino
authors.forename: Massimo
authors.initials: M
authors.lastname: Lombardi
authors.forename: Alessia
authors.initials: A
authors.lastname: Pepe
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003287:Contrast Media / Q000633:toxicity; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage / Q000633:toxicity*; D006453:Hemoglobinopathies / Q000150:complications*; D006801:Humans; D007674:Kidney Diseases; D008297:Male; D055815:Young Adult
chemical_list: D003287:Contrast Media; D005682:Gadolinium